Associated Papers
Protein aggregation in neurodegenerative diseases.
Wang J et al.
Chinese Medical Journal, 2025
The landscape of autosomal-dominant Alzheimer's disease: global distribution and age of onset.
Liu H et al.
Brain : a Journal of Neurology, 2025
39903689 (PubMed )
Supplement: awaf038_supplementary_data.zip › 3-Supplemental_Table2_AR_20250121_Jlli_B_Alz.pdf
The pathogenic APP N-terminal Val225Ala mutation alters tau protein liquid-liquid phase separation and exacerbates synaptic damage.
Chen J et al.
Molecular Psychiatry, 2025
AmazonForest: In Silico Metaprediction of Pathogenic Variants.
Palheta HGA et al.
Biology, 2022
Different clinical and neuroimaging features of Japanese dementia siblings with a new N-terminal mutation (Val225Ala) of APP gene.
Ohta Y et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 2020
APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease.
Giau VV et al.
International Journal of Molecular Sciences, 2019
Focusing mutations into the P. fluorescens esterase binding site increases enantioselectivity more effectively than distant mutations.
Park S et al.
Chemistry & Biology, 2005
Select a paper to view details